Gunderson Dettmer represented client HC9 Ventures in the launch of its $83 million new fund. HC9 focuses on early-stage healthcare software and services startups, with an emphasis on companies that address care delivery or operational needs for payers and providers. The new capital will be used to invest in companies that will shape the future of healthcare. 

In the announcement of the new fund, co-founder and general partner of HC9 Richard Lungen said, “There are obviously many sources of capital for an emerging, early-stage business and we wanted to be different. What makes us unique are a few things. Predominantly, the composition of our capital is absolutely unique. We were intentional to bring together a community of healthcare leaders as our only source of capital.”

The Gunderson Dettmer fund formation team was led by Jay Hachigian and included Emma Eriksson Broomhead and Garabed Koosherian.

Company
HC9 Ventures